Instituto de Ciências Biológicas, Médicas e da Saúde, Universidade Paranaense, Umuarama, PR, Brazil.
J Ethnopharmacol. 2013 Oct 28;150(1):154-61. doi: 10.1016/j.jep.2013.08.032. Epub 2013 Aug 27.
Although Maytenus ilicifolia is used in Brazilian folk medicine as a diuretic drug, no study has been conducted to this date in order to evaluate this ethnopharmacological statement. So, the aim of this study was to evaluate possible mechanisms involved in acute diuretic activity of the ethanolic supernatant of the infusion (SEI) obtained from Maytenus ilicifolia and to assess its relationship with a hypotensive activity by a bioassay-guided fractionation using normotensive Wistar rats.
The preparation obtained from the infusion (SEI) and their respective fractions (Fr·H2O and Fr·EtOAc) were orally administered in a single dose to rats. The urine excretion rate, pH, density, conductivity and content of Na(+), K(+), Cl(-) and HCO3(-) were measured in the urine of saline-loaded animals. Samples of the concentration of electrolytes, urea, creatinine, aldosterone, vasopressin and angiotensin converting enzyme (ACE) activity were evaluated in collected serum. The hypotensive activity and the involvement of nitric oxide, bradykinin and prostaglandin/cAMP pathway in the hypotensive and diuretic effects were also determined.
Water and Na(+) excretion rate were significantly increased by Fr·EtOAc and the arterial pressure was significantly reduced, while the urinary excretion of potassium and chloride were reduced. Pre-treatment with indomethacin or DDA (2',5'-dideoxyadenosine) significantly reduced the hypotensive and diuretic activity observed. All other parameters evaluated were not affected by any treatment.
The present study reveals that Fr·EtOAc obtained from Maytenus ilicifolia may present compounds responsible for diuretic and hypotensive activities, and this effect, could involve the prostaglandin/cAMP pathway.
尽管 Maytenus ilicifolia 被巴西民间医学用作利尿剂药物,但迄今为止,尚无研究评估这种民族药理学说法。因此,本研究的目的是评估从 Maytenus ilicifolia 获得的浸膏的乙醇上清液(SEI)的急性利尿活性涉及的可能机制,并通过使用正常血压 Wistar 大鼠的生物测定指导的分级分离来评估其与降压活性的关系。
从浸膏(SEI)获得的制剂及其各自的馏分(Fr·H2O 和 Fr·EtOAc)以单剂量口服给予大鼠。在盐水负荷动物的尿液中测量尿液排泄率、pH 值、密度、电导率以及 Na(+)、K(+)、Cl(-) 和 HCO3(-) 的含量。在收集的血清中评估电解质、尿素、肌酐、醛固酮、血管加压素和血管紧张素转换酶(ACE)活性的样本浓度。还确定了降压活性以及一氧化氮、缓激肽和前列腺素/cAMP 途径在降压和利尿作用中的参与。
Fr·EtOAc 显著增加水和 Na(+)的排泄率,显著降低动脉压,同时降低钾和氯的尿排泄。预先用吲哚美辛或 DDA(2',5'-二脱氧腺苷)预处理可显著降低观察到的降压和利尿活性。评价的所有其他参数均不受任何处理的影响。
本研究表明,从 Maytenus ilicifolia 获得的 Fr·EtOAc 可能含有负责利尿和降压活性的化合物,并且这种作用可能涉及前列腺素/cAMP 途径。